Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06304207 · ClinicalTrials.gov registry record · NA

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

A NA study of COPD and Interstitial Lung Disease, sponsored by MGH Institute of Health Professions.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06304207: Recruiting NA study of COPD and Interstitial Lung Disease, sponsored by MGH Institute of Health Professions.

NCT06304207 is a NA study of COPD and Interstitial Lung Disease that is actively recruiting participants, run by MGH Institute of Health Professions. The registered enrollment target is 30 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06304207, a NA study of COPD and Interstitial Lung Disease, is actively recruiting participants, sponsored by MGH Institute of Health Professions.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial is to compare telehealth and onsite supervised maintenance exercise program for adults with Chronic Lung Disease. The specific aims of the study are: * To compare 8-week supervised maintenance program delivered onsite and via tele-rehab with no maintenance for patients with Chronic Lung Disease following discharge from traditional exercise or physical therapy or onsite outpatient rehabilitation programs on clinical outcomes (dyspnea, exercise capacity, physical function, physical activity, and quality of life) at 8 weeks and 4-months post-intervention. * To compare the differences in dyspnea, exercise capacity, physical function, physical activity, and quality of life between an 8-week maintenance program delivered onsite and via tele-rehab at 8-weeks and 4-months post-intervention in patients with Chronic Lung Disease following discharge from traditional onsite outpatient rehabilitation. Participants in both intervention groups (onsite and tele-rehab) will undergo a baseline onsite assessment followed by an 8-week supervised exercise intervention either onsite or in a telehealth setting. Control group will receive biweekly check in calls, but no active intervention.

Interventions

  • COMBINATION_PRODUCT Onsite Maintenance Exercise Training
  • COMBINATION_PRODUCT Telehealth Maintenance Exercise

Study Locations (1)

Massachusetts

  • MGH Institute of Health Professions - Charlestown

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-09-01
Est. Completion 2026-03-01
Phase NA

What NCT06304207 shows while recruiting

NCT06304207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower).

The record links to 10 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Onsite Maintenance Exercise Training is the first listed.

NCT06304207 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06304207 about?

NCT06304207 is a clinical study titled "Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease". The goal of this pilot clinical trial is to compare telehealth and onsite supervised maintenance exercise program for adults with Chronic Lung Disease. The specific aims of the study are: * To compare 8-week supervised maintenance program delivered onsite and via tele-rehab with no maintenance for...

What is the current status of trial NCT06304207?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-09-01. Estimated completion is 2026-03-01.

What conditions does trial NCT06304207 study?

This clinical trial studies the following conditions: COPD, Interstitial Lung Disease, Pulmonary Fibrosis, Bronchiectasis, Chronic Lung Disease.

What interventions are being tested in trial NCT06304207?

The interventions under investigation include: Onsite Maintenance Exercise Training (COMBINATION_PRODUCT), Telehealth Maintenance Exercise (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT06304207?

This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06304207 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06304207's enrollment target sits among peer trials

30 64th of 85 higher than 16 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06304207, the US trial registry maintained by the National Library of Medicine. NCT06304207 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.